2121 - 2130 of 7665 Results
Title
Year
-
RESTRICTEDTitle: Disease modifying therapies for Parkinson's disease: Novel targetsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 201Issue #:Start Page: 108839End Page: 108839Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108839Citation Count: 4
- Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice2021RESTRICTEDTitle: Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in miceJournal Name: Cell Reports MedicinePublisher: Elsevier BVVol: 2Issue #: 12Start Page: 100455End Page: 100455Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.xcrm.2021.100455Best OA location URL: http://www.cell.com/article/S2666379121003232/pdfCitation Count: 17
-
RESTRICTEDTitle: Falling down the digital divide: A cautionary taleJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 93Issue #:Start Page: 33End Page: 34Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.032Best OA location URL: http://www.prd-journal.com/article/S1353802021003953/pdfCitation Count: 3
- Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson’s patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006)2021RESTRICTEDTitle: Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson’s patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006)Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 57Issue #:Start Page: 102569End Page: 102569Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2021.102569Best OA location URL: https://doi.org/10.1016/j.scr.2021.102569Citation Count: 2
- Generation of two human induced pluripotent stem cell lines (iPSCs) with mutations of the α-synuclein (SNCA) gene associated with Parkinson’s disease; the A53T mutation (LCSBi003) and a triplication of the SNCA gene (LCSBi007)2021RESTRICTEDTitle: Generation of two human induced pluripotent stem cell lines (iPSCs) with mutations of the α-synuclein (SNCA) gene associated with Parkinson’s disease; the A53T mutation (LCSBi003) and a triplication of the SNCA gene (LCSBi007)Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 57Issue #:Start Page: 102600End Page: 102600Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2021.102600Best OA location URL: https://doi.org/10.1016/j.scr.2021.102600Citation Count: 0
-
RESTRICTEDTitle: LRRK2 signaling in neurodegeneration: two decades of progressJournal Name: Essays in BiochemistryPublisher: Portland Press Ltd.Vol: 65Issue #: 7Start Page: 859End Page: 872Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1042/ebc20210013Citation Count: 9
-
RESTRICTEDTitle: Neuropathological evidence of body-first vs. brain-first Lewy body diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 161Issue #:Start Page: 105557End Page: 105557Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105557Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105557Citation Count: 81
-
RESTRICTEDTitle: Programmed autophagy prevents excess organelle baggage during neurogenesisJournal Name: Molecular CellPublisher: Elsevier BVVol: 81Issue #: 24Start Page: 4960End Page: 4961Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oa, publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.molcel.2021.11.034Best OA location URL: https://doi.org/10.1016/j.molcel.2021.11.034Citation Count: 0
- Protocol for the DeFOG trial: A randomized controlled trial on the effects of smartphone-based, on-demand cueing for freezing of gait in Parkinson's disease2021RESTRICTEDTitle: Protocol for the DeFOG trial: A randomized controlled trial on the effects of smartphone-based, on-demand cueing for freezing of gait in Parkinson's diseaseJournal Name: Contemporary Clinical Trials CommunicationsPublisher: Elsevier BVVol: 24Issue #:Start Page: 100817End Page: 100817Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.conctc.2021.100817Best OA location URL: https://doi.org/10.1016/j.conctc.2021.100817Citation Count: 11
-
RESTRICTEDTitle: Rab GTPases in Parkinson's disease: a primerJournal Name: Essays in BiochemistryPublisher: Portland Press Ltd.Vol: 65Issue #: 7Start Page: 961End Page: 974Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1042/ebc20210016Best OA location URL: https://portlandpress.com/essaysbiochem/article-pdf/65/7/961/926977/ebc-2021-0016c.pdfCitation Count: 12